Pharma and healthcare: sector news on Thursday 22 October 2026
Average tone +7.2 (strongly positive) across 5 companies with relevant coverage, from 75 stories.
How to read a score. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Company by company
| Company | Tone | Stories | What the coverage was about |
|---|---|---|---|
| GSK | +10.0 | 37 | |
| AstraZeneca | +8.3 | 28 | Coverage focused on positive Phase III Tezspire results in eosinophilic esophagitis, an FDA approval for Ultomiris in a rare kidney disease, and a new AI clinical trials partnership with Oracle. |
| Convatec | +8.0 | 6 | Coverage centred on JP Morgan backing Convatec's full-year guidance ahead of a trading update, easing earlier worries, and shares rose and outperformed the market. |
| Haleon | +6.0 | 2 | Coverage was mainly a report that Haleon had tidied its debt after raising its payout, which leans positive. |
| Smith & Nephew | +3.2 | 2 | Coverage centred on the European launch of CARTIHEAL AGILI-C and whether it can help the company regain momentum. |
Strongest stories in the sector
- +10.0 US approval of Hibsago for chronic hepatitis B.
- +10.0 FDA approval of potential functional cure.
- +10.0 Approved as first functional cure.
- +10.0 The first medicine of its type for hepatitis B receives approval.
- +10.0 FDA nod for functional cure.
- +10.0 Functional cure receives approval in the US.
- +10.0 First antisense treatment approved for hepatitis B.
- +10.0 First ASO approved in chronic hepatitis B.
- +10.0 FDA approval for chronic hepatitis B.
- +10.0 Hibsago is approved by the FDA.
- +10.0 FDA approval of hepatitis B drug.
- +10.0 Bepirovirsen injection gets the FDA's approval.
Pharma and healthcare: every day · FTSE 100 overview for the day
Follow by email
A short, free morning email on how the news treated the Pharma and healthcare sector: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.